Alfred Sandrock, EVP CMO Neuro & Neurodegenerat at BIOGEN INC. (BIIB), sold 834 shares at $277.00 ($230K) on 2015-12-04, disclosed to the SEC on 2015-12-07.
Scheduled sale ($230k) by EVP CMO Neuro & Neurodegenerat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.44 | 393 | $108K | 47.0% |
| 2 | $277.00 | 441 | $122K | 53.0% |
| Total | $276.26 avg | 834 | $230K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |